Academic
Publications
Low Molecular Weight Heparin in Atrial Fibrillation Management: Facts, Fiction, Future

Low Molecular Weight Heparin in Atrial Fibrillation Management: Facts, Fiction, Future,Michael H. Kim,Richard G. Trohman,Kim A. Eagle

Low Molecular Weight Heparin in Atrial Fibrillation Management: Facts, Fiction, Future   (Citations: 1)
BibTex | RIS | RefWorks Download
Background: Atrial fibrillation (AF) is the most common sustained arrhythmia and various AF dis- ease management strategies can be utilized. Methods: A prospective, randomized pilot study of two AF disease management strategies was conducted at a single university hospital in patients newly diagnosed with AF. The impact of low molecular weight heparin (LMWH) on AF management strategies is discussed with respect to the current guidelines for AF management, existing data on LMWH for AF, and recent investiga- tions pertaining to AF. Results: 18 patients were enrolled. The accelerated emergency department based strategy utilizing LMWH resulted in a significant reduction in length of stay (2.1 ± 2.3 versus <1 day) and a trend toward lower costs ($1,706 ± 1,512 versus $879 ± 394; p = 0.15) when com- pared to the more traditional strategy of hospital admis- sion. Measured clinical outcomes were similar for both treatment strategies. Conclusions: The investigation showed that an out- patient, emergency department based disease manage- ment strategy for new, uncomplicated AF could result in clinically acceptable, cost-effective innovations in AF treatment strategies. LMWH is an example of an agent allowing innovations in disease management strategies.
Published in 2004.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: